These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 29246832)

  • 41. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.
    Sepulveda P; Hontebeyrie M; Liegeard P; Mascilli A; Norris KA
    Infect Immun; 2000 Sep; 68(9):4986-91. PubMed ID: 10948115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in mice.
    Franchin G; Pereira-Chioccola VL; Schenkman S; Rodrigues MM
    Infect Immun; 1997 Jul; 65(7):2548-54. PubMed ID: 9199418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-lytic antibodies in H-2-controlled resistance to acute infection with Trypanosoma cruzi.
    Juri MA; Ferreira A; Ramos A; Hoecker G
    Braz J Med Biol Res; 1990; 23(8):685-95. PubMed ID: 2129269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lytic antibodies elicited by Trypanosoma cruzi infection recognize epitopes present on both bloodstream trypomastigote and epimastigote forms of parasite.
    Takehara HA; Cardoso DF; da Silva AM; Mota I
    Rev Inst Med Trop Sao Paulo; 1988; 30(5):351-6. PubMed ID: 2471248
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
    Caballero ZC; Sousa OE; Marques WP; Saez-Alquezar A; Umezawa ES
    Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
    Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
    Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi.
    Carlier Y; Rivera MT; Truyens C; Goldman M; Lambert P; Flament J; Bauwens D; Vray B
    Infect Immun; 1987 Oct; 55(10):2496-501. PubMed ID: 3115899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trypanosoma cruzi glutathione-binding proteins: immunogenicity during human and experimental Chagas' disease.
    Plumas-Marty B; Verwaerde C; Loyens M; Velge P; Taibi A; Cesbron MF; Capron A; Ouaissi MA
    Parasitology; 1992 Feb; 104 Pt 1():87-98. PubMed ID: 1614743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunological aspects of infection of 6 inbred strains of mice by 3 different strains of Trypanosoma cruzi].
    Andrade V; Barral-Netto M; Andrade SG; Magalhães JB
    Mem Inst Oswaldo Cruz; 1985; 80(2):203-11. PubMed ID: 3939148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
    Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human infection and risk of transmission of Chagas disease in Hidalgo State, Mexico.
    Becerril-Flores MA; Rangel-Flores E; Imbert-Palafox JL; Gómez-Gómez JV; Figueroa-Gutiérrez AH
    Am J Trop Med Hyg; 2007 Feb; 76(2):318-23. PubMed ID: 17297042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Widespread Trypanosoma cruzi infection in government working dogs along the Texas-Mexico border: Discordant serology, parasite genotyping and associated vectors.
    Meyers AC; Meinders M; Hamer SA
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005819. PubMed ID: 28787451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
    Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
    Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence.
    Rowland E; Luo H; McCormick T
    J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initial induction of immunity, followed by suppression of responses to parasite antigens during Trypanosoma cruzi infection of mice.
    Tarleton RL; Scott DW
    Parasite Immunol; 1987 Sep; 9(5):579-89. PubMed ID: 2960943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease.
    Zwirner NW; Malchiodi EL; Chiaramonte MG; Fossati CA
    Infect Immun; 1994 Jun; 62(6):2483-9. PubMed ID: 7514576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential mucosal infectivity of different life stages of Trypanosoma cruzi.
    Hoft DF
    Am J Trop Med Hyg; 1996 Oct; 55(4):360-4. PubMed ID: 8916789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of peptide-based lineage-specific serology for chronic Chagas disease: geographical and clinical distribution of epitope recognition.
    Bhattacharyya T; Falconar AK; Luquetti AO; Costales JA; Grijalva MJ; Lewis MD; Messenger LA; Tran TT; Ramirez JD; Guhl F; Carrasco HJ; Diosque P; Garcia L; Litvinov SV; Miles MA
    PLoS Negl Trop Dis; 2014 May; 8(5):e2892. PubMed ID: 24852444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.